维普中文期刊产品整合服务
9篇 您的检索式:作者名="Aksel Foss"
    题名 作者 年代 出处 被引量
1Liver Transplantation for Nonresectable Liver Metastases From Colorectal Cancer显示文摘Morten Hagness Aksel Foss P?l-Dag Line Tim Scholz P?l Foyn J?rgensen Bjarte Fosby Kirsten Muri Boberg ?ystein Mathisen Ivar P. Gladhaug Tor Skatvedt Egge Steinar Solberg John Hausken Svein Dueland 2013Annals of Surgery2013,,5:4
2Liver transplantation for cholangiocarcinoma: Selection is essential for acceptable results显示文摘Styrbj?rn Friman Aksel Foss Helena Isoniemi Michael Olausson Krister H?ckerstedt Shinji Yamamoto Tom Hemming Karlsen Magnus Rizell Bo-G?ran Ericzon 2011Scandinavian Journal of Gastroenterology2011,,3:1
3Fulminant hepatic failure: Outcome after listing for highly urgent liver transplantation—12 years experience in the nordic countries显示文摘Bj?rn Brands?ter Krister H?ckerstedt Styrbj?rn Friman Bo-G?ran Ericzon Preben Kirkegaard Helena Isoniemi Michael Olausson Ulrika Broome Lars Schmidt Aksel Foss Kristian Bj?ro 2002Liver Transplantation2002,,11:1
4Transplantation With Livers From Deceased Donors Older Than 75 Years显示文摘Trygve Thorsen Einar Martin Aandahl William Bennet Michael Olausson Bo-G?ran Ericzon Greg Nowak Frans Duraj Helena Isoniemi Allan Rasmussen Tom H. Karlsen Aksel Foss 2015Transplantation2015,,12:1
5Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis显示文摘Kirsten Muri Boberg Peter Jebsen Ole Petter Clausen Aksel Foss Lars Aabakken Erik Schrumpf 2006Journal of Hepatology2006,,4:1
6Immunosuppression After Liver Transplantation for Primary Sclerosing Cholangitis Influences Activity of Inflammatory Bowel Disease显示文摘Kristin Kaasen J?rgensen Lina Lindstr?m Milada Cvancarova Tom H. Karlsen Maria Castedal Styrbj?rn Friman Erik Schrumpf Aksel Foss Helena Isoniemi Arno Nordin Kathrine Holte Allan Rasmussen Annika Bergquist Morten H. Vatn Kirsten Muri Boberg 2013Clinical Gastroenterology and Hepatology2013,,5:1
7Differences in long‐term survival among liver transplant recipients and the general population: A population‐based nordic study显示文摘Fredrik ?berg Mika Gissler Tom H. Karlsen Bo‐G?ran Ericzon Aksel Foss Allan Rasmussen William Bennet Michael Olausson P?l‐Dag Line Arno Nordin Annika Bergquist Kirsten Muri Boberg Maria Castedal Christian Ross Pedersen Helena Isoniemi 2015Hepatology2015,,2:1
8Colorectal neoplasia in patients with primary sclerosing cholangitis undergoing liver transplantation: a Nordic multicenter study显示文摘Kristin Kaasen J?rgensen Lina Lindstr?m Milada Cvancarova Maria Castedal Styrbj?rn Friman Erik Schrumpf Aksel Foss Helena Isoniemi Arno Nordin Kathrine Holte Allan Rasmussen Annika Bergquist Morten H Vatn Kirsten Muri Boberg 2012Scandinavian Journal of Gastroenterology (-)2012,,8:1
9HLA variants related to primary sclerosing cholangitis influence rejection after liver transplantation显示文摘AIM:To investigate influence of human leukocyte antigen(HLA)and killer immunoglobuline-like receptor(KIR)genotypes on risks of acute rejection(AR)after liver transplantation(LTX).METHODS:In this retrospective study we included143 adult donor-recipient pairs with a minimum of 6mo follow-up after LTX for whom DNA was available from both donor and recipients.Clinical data,all early complications including episodes and severity of AR and graft/patient survival were registered.The diagnosis of AR was based on clinical,biochemical and histological criteria.All suspected episodes of AR were biopsy confirmed.Key classical HLA loci(HLA-A,HLA-B,HLA-C and HLA-DRB1)were genotyped using Sanger sequencing.16 KIR genes were genotyped using a novel real time PCR approach which allows for determination of the diploid copy number of each KIR gene.Immunohistochemical staining for T(CD3),B(CD20)and natural killer(NK)cells(CD56 and CD57)were performed on liver biopsies from 3 different patient groups[primary sclerosing cholangitis(PSC),primary biliary cirrhosis and non-autoimmune liver disease],10 in each group,with similar grade of AR.RESULTS:Fourty-four(31%)patients were transplanted on the basis of PSC,40%of them had AR vs 24%in the non-PSC group(P=0.04).No significant impact of donor-recipient matching for HLA and KIR genotypes was detected.In the overall recipient population an increased risk of AR was detected for HLA-B*08(P=0.002,OR=2.5;95%CI:1.4-4.6),HLA-C*07(P=0.001,OR=2.4;95%CI:1.4-4.0)and HLA-DRB1*03(P=0.03,OR=1.9;95%CI:1.0-3.3)and a decreased risk for HLA-DRB1*04(P=0.001,OR=0.2;95%CI:0.1-0.5).For HLA-B*08,HLA-C*07 and DRB1*04 the associations remained evident in a subgroup analysis of non-PSC recipients(P=0.04,P=0.003 and P=0.02,respectively).In PSC recipients corresponding P values were 0.002,0.17 and 0.01 for HLA-B*08,HLA-C*07and DRB1*04,respectively.A dosage effect of AR prevalence according to the PSC associated HLA alleles was also notable in the total recipient population.For HLA-B*08 the frequency of AR was 56%in HLA-B*08homozygous recipients,39%in heterozygous recipients and 21%in recipients lacking HLA-B*08(P=0.02).The same was observed for the HLA-C*07 allele with AR in 57%,27%and 18%in recipients being homozygous,heterozygous and lacking HLA-C*07 respectively(P=0.003).Immunohistochemical analysis showed similar infiltration of T,B and NK cells in biopsies with AR in all three groups.CONCLUSION:We found significant associations between the PSC-associated HLA-B*08,HLA-C*07,HLADRB1*03 and HLA-DRB1*04 alleles and risk of AR in liver transplant recipients.Bjarte Fosby Sigrid Nss Johannes R Hov James Traherne Kirsten M Boberg John Trowsdale Aksel Foss Pl-Dag Line Andre Franke Espen Melum Helge Scott Tom H Karlsen 2014World Journal of Gastroenterology2014,20,14:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费